Richardson, Tom G. http://orcid.org/0000-0002-7918-2040
Crouch, Daniel J. M.
Power, Grace M. http://orcid.org/0000-0002-5702-7728
Morales-Berstein, Fernanda http://orcid.org/0000-0002-8237-2021
Hazelwood, Emma http://orcid.org/0000-0002-4888-6037
Fang, Si
Cho, Yoonsu http://orcid.org/0000-0001-6118-6652
Inshaw, Jamie R. J.
Robertson, Catherine C. http://orcid.org/0000-0002-1120-1786
Sidore, Carlo
Cucca, Francesco http://orcid.org/0000-0002-7414-1995
Rich, Steven S. http://orcid.org/0000-0003-3872-7793
Todd, John A. http://orcid.org/0000-0003-2740-8148
Davey Smith, George http://orcid.org/0000-0002-1407-8314
Funding for this research was provided by:
RCUK | Medical Research Council (MR/S003886/1, MR/N0137941/1)
Wellcome Trust (108902/Z/15/Z, 218495/Z/19/Z, 217065/Z/19/Z, 091157/Z/10/Z, 107212/Z/15/Z, 203141/Z/16/Z)
JDRF (9-2011-253, 5-SRA-2015-130-A-N, 4-SRA-2017-473-A-N)
Article History
Received: 9 April 2021
Accepted: 8 April 2022
First Online: 28 April 2022
Competing interests
: J.A.T. is a member of the Human Genetics Advisory Board of GSK. T.G.R. is employed part-time by Novo Nordisk outside of this work. The remaining authors declare no competing interests.